Detalhe da pesquisa
1.
Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
Clin Infect Dis
; 73(2): e362-e370, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32590841
2.
Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Clin Infect Dis
; 69(8): 1278-1287, 2019 09 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30759187